Australija - anglų - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: titanium dioxide; purified water; sodium lauryl sulfate; iron oxide red; gelatin; maltodextrin; microcrystalline cellulose; sodium ascorbate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris

Australija - anglų - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 25 mg - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; purified water; iron oxide red; sodium ascorbate; iron oxide yellow; gelatin; maltodextrin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris

Australija - anglų - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - acitretin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; iron oxide yellow; microcrystalline cellulose; titanium dioxide; spray-dried liquid glucose; sodium ascorbate; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of severe intractable psoriasis in all its forms. severe forms of disorders of keratinisation such as: hyperkeratosis palmaris et plantaris; pustulosis palmaris et plantaris; ichthyosis; keratosis follicularis (darier's disease); lichen planus affecting the skin or the mucosae; pityriasis rubra pilaris.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: iron oxide yellow; spray-dried liquid glucose; iron oxide black; titanium dioxide; iron oxide red; microcrystalline cellulose; gelatin; sodium ascorbate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of severe intractable psoriasis in all its forms. severe forms of disorders of keratinisation such as: hyperkeratosis palmaris et plantaris; pustulosis palmaris et plantaris; ichthyosis; keratosis follicularis (darier's disease); lichen planus affecting the skin or the mucosae; pityriasis rubra pilaris.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - acitretin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; iron oxide black; iron oxide red; sodium ascorbate; microcrystalline cellulose; iron oxide yellow; spray-dried liquid glucose; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of severe intractable psoriasis in all its forms. severe forms of disorders of keratinisation such as: hyperkeratosis palmaris et plantaris; pustulosis palmaris et plantaris; ichthyosis; keratosis follicularis (darier's disease); lichen planus affecting the skin or the mucosae; pityriasis rubra pilaris.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: iron oxide red; spray-dried liquid glucose; iron oxide yellow; iron oxide black; gelatin; microcrystalline cellulose; sodium ascorbate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of severe intractable psoriasis in all its forms. severe forms of disorders of keratinisation such as: hyperkeratosis palmaris et plantaris; pustulosis palmaris et plantaris; ichthyosis; keratosis follicularis (darier's disease); lichen planus affecting the skin or the mucosae; pityriasis rubra pilaris.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

coria laboratories - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 60 mg in 1 g - for dermatologic use: salex is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: salex is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salex should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salex should not be used in children under 2 years of age.

Europos Sąjunga - anglų - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - acitretin -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - acitretin -